Abstract

The effect of immediate volume replacement with latissimus dorsi miniflaps on the outcome of breast-conserving surgery

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract P3-18-14: Assessment of quality of life and objective cosmetic outcome of breast conserving surgery with or without latissimus dorsi mini-flap in breast cancer
Jang-Il Kim ... Hong Kyu Kim
Cancer Research | VOL. 82
Jang-Il Kim, et. al.Jang-Il Kim ... Hong Kyu Kim
15 Feb 2022
Pedicled Descending Branch Latissimus Dorsi Mini-flap for Repairing Partial Mastectomy Defect: A New Technique.
Junhao Huang ... Zeming Xie
Plastic and reconstructive surgery. Global open | VOL. 6
Junhao Huang, et. al.Junhao Huang ... Zeming Xie
01 Mar 2018
Recent Progress with Breast-Conserving Volume Replacement Using Latissimus Dorsi Miniflaps in UK Patients.
Nirmala Paramanathan ... Richard M Rainsbury
Breast cancer (Tokyo, Japan) | VOL. 5
Nirmala Paramanathan, et. al.Nirmala Paramanathan ... Richard M Rainsbury
01 Apr 1998
Extending the role of breast-conserving surgery by immediate volume replacement
R M Rainsbury ... Ch Papp
British Journal of Surgery | VOL. 84
R M Rainsbury, et. al.R M Rainsbury ... Ch Papp
08 Dec 2005
View more papers

More From: European Journal of Cancer

Paper Title
Journal
Date
Author
Editorial Board
-
European Journal of Cancer | VOL. -
--
01 Jun 2024
OpenAI’s GPT-4o in surgical oncology: Revolutionary advances in generative artificial intelligence
Ning Zhu ... Haiyang Wu
European Journal of Cancer | VOL. 206
Ning Zhu, et. al.Ning Zhu ... Haiyang Wu
26 May 2024
A single-arm, multicenter, phase 2 clinical study of recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate (MRG002) in HER2-positive unresectable locally advanced or metastatic urothelial carcinoma
Wang Qu ... Aiping Zhou
European Journal of Cancer | VOL. 205
Wang Qu, et. al.Wang Qu ... Aiping Zhou
10 May 2024
Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial
Pasquale Rescigno ... Johann De Bono
European Journal of Cancer | VOL. 205
Pasquale Rescigno, et. al.Pasquale Rescigno ... Johann De Bono
08 May 2024
View more papers